Bluspring Enterprises Ltd, India's only scaled, tech-enabled, safety & compliance-first, integrated infrastructure services enterprise, announced its financial results for Q3 FY2026. The company reported a 10% YoY growth in revenues and a 12% increase in EBITDA. EBITDA margins expanded by 37 bps QoQ. The company also reported a 54% YoY increase in PAT and a 54% YoY increase in EPS.
We delivered another robust quarter, achieving 10% year-on-year growth in revenues alongside a 12% increase in EBITDA. Our EBITDA margins have expanded by 37 bps quarter-on-quarter, driven by new business which were on-boarded at better margins, volume uptick and efficiency improvement measures. This performance is in line with the guidance provided at the beginning of the year, and we remain confident in sustaining this growth momentum.
Rashi Peripherals Limited, one of India’s leading value-added distributors of IT hardware, consumer technology, and enterprise solutions, announces its results for the third quarter of the financial year 2025-26. The company reported a 43% YoY growth in revenue, 453% YoY growth in EBITDA, and a 132% YoY growth in net profit.
We are pleased to report another strong quarter with solid performance across revenue, EBITDA, and PAT. Backed by our robust distribution network, pan-India presence, strong channel partner relationships, and value-added support, we continue to enable the adoption and deployment of complex, high-value technology solutions across the country.
Rashi Peripherals continued its growth momentum despite global market volatility and uncertainty. The industry is currently experiencing price uptrend in IT product prices due to global shortages and dollar appreciation. However, we turned this challenge into an opportunity, delivering 43% revenue growth and 132% PAT growth on a year-on-year basis.
Godrej Agrovet Limited has announced its financial results for the quarter and nine months ended December 31, 2025. The company reported an 11% increase in revenue and a 23% improvement in profitability in Q3 FY26.
Q3 FY26 has been an exceptional quarter for Godrej Agrovet, with robust double digit revenue growth of 11% and strong profitability improvement of 23% year-on-year. This strong performance was driven by sustained margin expansion across most of our key businesses, supported by sharp operational execution and a continued focus on value creation.
Manaksia Coated Metals & Industries, a leading coated steel manufacturer and exporter, has reported its unaudited financials for Q3 & 9M FY26. The company's net profit for 9M FY26 increased by 241.25% YoY to ₹ 35.32 Cr, with revenue for the same period increasing by 15.13% YOY to ₹ 667.52 Crore. The company's PAT for Q3 FY26 increased by 46.68% YoY to ₹ 7.35 Crore. Exports continue to be a key growth driver, contributing a meaningful share to overall revenues.
The 9 Months of FY26 marked another strong phase of growth and strategic progress for Manaksia Coated Metals & Industries Limited, underpinned by our continued focus on operational excellence, disciplined execution, and calibrated expansion. Operationally, we delivered resilient performance across our product lines, maintaining healthy utilisation levels in our colour-coating operations, supported by steady demand and efficient execution. Exports continued to be a key growth driver, contributing a meaningful share to overall revenues and reinforcing our expanding global footprint. During Q3 FY26, utilisation of the continuous galvanising line was temporarily subdued due to a planned plant shutdown undertaken for technology upgradation and transition to Alu-Zinc coating technology. This necessary shutdown and capacity curtailment restricted our ability to fully maximise sales and revenue during the quarter. We are pleased to inform that the Alu-Zinc line has now been successfully commissioned, with stable production and consistent quality achieved. This positions the company well to significantly boost production volumes, sales, and margins in Q4 FY26 and through FY27. The upgradation of the galvanising line to Alu-Zinc coating technology, with enhanced capacity of 1,80,000 MTPA, is a strategic milestone and is expected to drive up EBITDA margins by enabling a shift towards premium, high-value steel products. Going forward, the 7 MW captive solar power plant in Gujarat is expected to reduce power costs by 30-35% while enhancing sustainability. Contracts for the second colour-coating line have been awarded, with commissioning scheduled in Q1 FY27, further strengthening capacity for high-margin, value-added pre-painted steel products. From a balance sheet perspective, the company remains firmly on track to achieve a Net Debt to EBITDA ratio of under 1x by the end of FY26, a significant improvement from 1.93x in FY25, reflecting strong cash flows and prudent capital allocation. Looking ahead, the company is supported by a healthy export order book of approximately ₹ 350 crore, while the domestic market has entered its peak demand season. These factors, combined with newly commissioned capacities and an improving product mix, provide strong visibility for superior performance in the upcoming quarters. With a sharper focus on efficiency, sustainability, and value-added growth, we remain confident in delivering robust performance and long-term value creation for all stakeholders.
Aarti Drugs Limited, a Mumbai based diversified and fully integrated pharmaceutical company, reported its audited Financial Results for the Quarter and Nine Months ended 31st December 2025. The company's revenue grew by 8% YoY in Q3 FY26, with EBITDA and PAT standing at Rs. 56.3 crore and Rs. 40.5 crore respectively. The 9M FY26 PAT showed a 49% YoY growth.
During the third quarter of FY26, Aarti Drugs delivered a steady performance, supported by healthy traction in the domestic market and strong growth in the export formulations segment... We are confident in our ability to ramp up to 50% by March or April 2026... Our Salicylic Acid plant in Tarapur has hit a significant milestone, scaling to above ~300 tonnes per month recently... The Company remains focused on operational efficiency, margin improvement, and capacity ramp-up, while maintaining compliance with regulatory standards and capital discipline.
ADF Foods Limited, a leading manufacturer of prepared ethnic foods, announced Financial Results for the third quarter and nine months ended 315t December 2025. The company reported a consolidated revenue growth of 29.5% YoY to Rs. 191.0 Cr, with a consolidated EBITDA increase of 40.6% to Rs. 37.1 Cr., and a consolidated PAT increase of 55.7% to Rs. 29.2 Cr.*.
We delivered a strong performance in Q3 FY26, with consolidated revenues reaching an all-time high of Rs. 191.0 crores, representing a robust 29.5% year on year growth. This momentum was fuelled by the continued traction from new listings secured in the past few quarters and strengthening brand penetration across all our key markets. Despite prevailing tariff challenges, our U.S. business continues to show substantial progress, benefiting from the enhancement of our sales force and strategic distributor level changes implemented at the beginning of CY2025. Our consolidated EBITDA also reached a record Rs. 37.1 crores, with healthy margins of 19.4%. This was driven by an improved product mix and continued focus on cost optimization. Our flagship brand Ashoka continues to strengthen its market presence, and our mainstream brand Truly Indian has exceeded expectations with a marked acceleration in its growth trajectory. We have successfully completed pilot runs at our upcoming Surat Greenfield facility, and Phase 1 is on track to become fully operational by Q4 FY26.
Expleo Solutions Ltd, a global technology, engineering and consulting service provider, announced its Q3 and nine months of FY26 results. The company reported a Y-o-Y total income growth of 11.2% to Rs 2,897 million. The AI training initiative launched last quarter has begun to show encouraging results, driving measurable improvements in operational efficiency across multiple teams. The company remains optimistic about the growth opportunities in the North America and Middle East markets.
We delivered a strong quarter, recording year-on-year total revenue growth of 11.2% despite challenging market conditions, particularly in Europe, where we have a significant presence. We continue to remain optimistic about the growth opportunities in the North America and Middle East markets and expect their growth momentum to continue. Operationally, we delivered a strong performance in this quarter, with consistent improvement across all metrics. Digital services continued to grow, supported by accelerating AI monetization. Utilization remained at optimal levels, project SLAs were consistently met, attrition moderated, and cash generation from operations increased significantly. The AI training initiative launched last quarter has begun to show encouraging results, driving measurable improvements in operational efficiency across multiple teams. Our continued investments in Artificial Intelligence and Digital Transformation are translating into revenue traction, with AI and AI-enabled services creating scalable growth opportunities across the portfolio. We expect this momentum to strengthen, as these capabilities evolve into durable competitive advantages that enhance differentiation, deepen client relevance, and expand long-term value creation.
DAM Capital Advisors Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company executed 96 ECM transactions, raised ~INR 4,376 crore during the quarter, and has a robust IPO pipeline of 22 mandates. The total income stood at INR 69.9 crore for the quarter and INR 207.9 crore for the nine months. The profit after tax stood at INR 20.1 crore for the quarter and INR 72.4 crore for the nine months.
In Q3 FY26, the fund-raising environment was very selective and challenging... We remain disciplined and selective in bringing strong, well-governed companies to the capital markets... We are hoping for better market conditions to execute our existing IPO pipeline... Our priorities remain unchanged: consistent execution, strengthening core platforms, prudent risk management through an asset-light model and delivering long-term value for all stakeholders.
Dr. Agarwals Health Care Ltd has reported a 20.8% YoY increase in total income for the quarter and nine months ended December 31, 2025. The company's EBITDA and PAT have also grown by 23.6% YoY and 74.3% YoY respectively. The company performed 81,002 surgeries during the quarter, adding 14 new centers to its network.
The company does not provide any specific management comments in the document.
Signatureglobal (India) Ltd has reported its financial results for 9MFY26 and Q3FY26. The company's revenue stands at INR 14.9 bn for 9MFY26 and INR 2.8 bn for Q3FY26. There has been a significant improvement in adjusted gross margin from 27% in 9MFY25 to 31% in 9MFY26 and from 29% in Q3FY25 to 40% in Q3FY26. However, the company reported a loss after tax of INR 0.58 bn in 9MFY26 and INR 0.45 bn in Q3FY26. Pre-sales and sales realization have seen a decrease, but collections have improved. The net debt stands at INR 10.2 bn at the end of 9MFY26.
Kindly take the above information on record. For SIGNATUREGLOBAL (INDIA) LIMITED
Sheela Foam Ltd. has announced its Q3 & 9M FY26 financial results. The company has reported a YoY growth of 11% for Q3 and 7% for 9M FY26 in consolidated revenues. The consolidated PAT recorded at INR 53 cr for Q3 FY26 and INR 69 cr for 9M FY26. The consolidated core EBITDA grew by 39% YoY in Q3FY26 and 34% YoY in 9M FY26. The consolidated core EBITDA margins grew by 220 bps in Q3FY26 and 213 bps in 9M FY26.
The Kurlon acquisition has begun delivering tangible benefits, driving a turnaround at Sheela Foam Limited. The business has entered a phase of double-digit growth, with both the mattress and foam segments recording strong volume expansion. Profitability and cash generation have continued to improve sequentially each quarter, supported by improved performance across all key markets - India, Australia, and Spain. We remain confident in our ability to deliver sustained, profitable growth backed by robust cash generation, thereby creating long- term value for all stakeholders.
Restaurant Brands Asia Limited (RBA), earlier known as Burger King India Limited, reported Revenue from Operations (Standalone) at Rs. 5,773 million, an increase of 16.5% over the same period last year, driven by a same-store sales growth of 4.5%. Gross Margins were at 69.9%, rising by more than 210 bps over the same quarter in the preceding year. Standalone EBITDA for the quarter was at Rs. 953 million, growing by 20.9% year-on- year.
Our same-store sales growth for Burger King India of 4.5% this quarter marks 10 quarters of positive sales growth over the last 3 years. As consumers become more discerning, we will continue to earn their trust by delivering consistent everyday value, menu innovation and operations excellence across our restaurants. Going forward, we remain laser focused on leveraging our competitive advantages, increasing profitability and expanding our store footprint to drive long-term, sustainable growth for all our stakeholders.
Suraj Products Ltd has announced its Q3 and nine months results for the period ended December 31, 2025. The company's revenue from operations has increased by 24.88% compared to the same period last year.
The unaudited standalone financial results for the quarter and nine months ended December 31, 2025 have been reviewed and recommended by the audit committee on 3° February, 2026 and subsequently approved by the Board of Directors at its meeting held on 3 February, 2026. The unaudited standalone financial results for the quarter and nine Months ended December 31, 2025, have been subjected to Limited Review by Statutory Auditors of the Company and the Statutory auditor has issued an unmodified review report on unaudited financial results.
Nazara Technologies Limited announced its financial results for Q3FY26 and 9MFY26. In Q3FY26, Nazara delivered revenue of INR 406 crores, with an EBITDA of INR 67.8 crores, up 29.4% YoY and margins expanding to 16.7%. For 9MFY26, revenue grew 29.7% YoY to INR 1,431.2 crores, while EBITDA increased 73% YoY to INR 177.2 crores, with margins expanding to 12.4%.
Nazara continued to make strong progress in building a global gaming company. The quarter was driven by disciplined execution, improving operating efficiency, and multiple growth engines across new launches, live content expansion, and platform extensions. We remain focused on disciplined capital allocation, including through strategic acquisitions where Nazara’s operating platform can accelerate scale, improve unit economics, and drive long-term value creation.
Beryl Securities Ltd has reported a revenue growth of 53% to INR 186.58 Crore for Q3 2025. The financial results have been prepared in accordance with the recognition and measurement principles stated under Section 133 of the Companies Act, 2013.
The above financial results have been reviewed and recommended by the Audit Committee and subsequently by the Board of Directors. The figures for the previous periods have been regrouped/reclassified wherever necessary to conform to current period classification.
HFCL Limited, a leading technology enterprise focused on telecom, digital infrastructure and defence, reported steady operational progress during the third quarter of FY26. The quarter was marked by strong export momentum, an improving revenue mix, sustained order inflows, continued capacity expansion, and meaningful advances in defence indigenisation, positioning the Company well for sustained growth and profitability.
Mankind Pharma, India's fourth largest pharmaceutical Company, has announced its financial results for the third quarter and nine months ended 31st December 2025. The Company's revenue increased by 11.5% YoY, with adj. EBITDA margins of 25.9%. The chronic share increased by 200bps YoY to 39.3% driven by strong growth of 16.7% in cardiac and 14.4% in anti-diabetes. Revenue from OTC grew by 5.2% in Q3FY26 vs -2.6% in Q2FY26.
Mankind’s revenue increased 11.5% YoY, with adj. EBITDA margins of 25.9%, primarily due to improvement in domestic pharma and BSV consolidation. Mankind’s chronic share increased by 200bps YoY to 39.3% driven by strong growth of 16.7% in cardiac and 14.4% in anti-diabetes. Revenue from OTC grew by 5.2% in Q3FY26 vs -2.6% in Q2FY26. We expect growth to improve further. BSV growth initiatives progressing well; Strong double-digit growth in Q3. We remain confident of delivering long term sustainable growth anchored by four key pillars - steady base business, fast growing specialty chronic, high potential OTC business, and super specialty BSV portfolio.”
Kinetic Engineering Ltd. has reported a 33% year-on-year growth in consolidated revenue from operations, reaching 238.37 crore for the quarter ended December 2025. The company has sold over 600 electric vehicles (EVs) to date and plans to expand its dealer network to 715 outlets by the end of February. The leadership team has been strengthened with the appointment of Mr. Rajesh Dhongade as Chief Operating Officer to support the next phase of EV and manufacturing scale-up.
Our EV business is entering a phase of measured scale-up, supported by growing customer acceptance, expanding retail presence, and stronger operational execution. Crossing 600 EV sales and steadily expanding our dealer network reflects the confidence the market is showing in our product and approach. At the same time, the improvement in revenues highlights the strength of our manufacturing backbone. As we scale further, strengthening leadership will be critical to sustaining quality, efficiency, and long-term growth.
Solar Industries India Limited (SIIL) announced its unaudited financial results for the quarter & nine month ended Dec 31,2025. The company posted the highest quarterly revenue at ~ 2548cr, up by 29%, and net profit at < 467cr, up by 38%. The highest ever quarterly sales, EBIDTA, and PAT were also reported.
Our Q3 results highlight the strength of our strategic execution, contributing to a meaningful uplift in net revenue from ~ 1973cr to € 2548cr yoy. We have registered strongest quarter again with growth in revenue of 29%.
